KALV logo

KalVista Pharmaceuticals, Inc. (KALV) CAPEX

annual CAPEX:

$929.00K+$486.00K(+109.71%)
April 30, 2025

Summary

  • As of today (September 13, 2025), KALV annual capital expenditures is $929.00 thousand, with the most recent change of +$486.00 thousand (+109.71%) on April 30, 2025.
  • During the last 3 years, KALV annual CAPEX has fallen by -$2000.00 (-0.21%).
  • KALV annual CAPEX is now -34.90% below its all-time high of $1.43 million, reached on April 30, 2018.

Performance

KALV CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKALVcash flow metrics

quarterly CAPEX:

N/A
July 31, 2025

Summary

  • KALV quarterly capital expenditures is not available.

Performance

KALV quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVcash flow metrics

TTM CAPEX:

N/A
July 31, 2025

Summary

  • KALV TTM capital expenditures is not available.

Performance

KALV TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVcash flow metrics

KALV CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+109.7%--
3 y3 years-0.2%--
5 y5 years+322.3%--

KALV CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.3%+109.7%
5 y5-year-22.3%+1032.9%
alltimeall time-34.9%+5061.1%

KALV CAPEX History

DateAnnualQuarterlyTTM
Apr 2025
$929.00K(+109.7%)
$776.00K(+3133.3%)
$929.00K(+63.3%)
Jan 2025
-
$24.00K(-77.8%)
$569.00K(+0.9%)
Oct 2024
-
$108.00K(+414.3%)
$564.00K(+23.1%)
Jul 2024
-
$21.00K(-95.0%)
$458.00K(+3.4%)
Apr 2024
$443.00K(-63.0%)
$416.00K(+2089.5%)
$443.00K(+361.5%)
Jan 2024
-
$19.00K(+850.0%)
$96.00K(+4.3%)
Oct 2023
-
$2000.00(-66.7%)
$92.00K(-67.4%)
Jul 2023
-
$6000.00(-91.3%)
$282.00K(-76.4%)
Apr 2023
$1.20M(+28.5%)
$69.00K(+360.0%)
$1.20M(-1.4%)
Jan 2023
-
$15.00K(-92.2%)
$1.21M(-13.4%)
Oct 2022
-
$192.00K(-79.1%)
$1.40M(-10.5%)
Jul 2022
-
$920.00K(+969.8%)
$1.56M(+68.0%)
Apr 2022
-
$86.00K(-57.4%)
$931.00K(+6.0%)
Apr 2022
$931.00K(+1035.4%)
-
-
Jan 2022
-
$202.00K(-43.3%)
$878.00K(+27.2%)
Oct 2021
-
$356.00K(+24.0%)
$690.00K(+98.8%)
Jul 2021
-
$287.00K(+769.7%)
$347.00K(+323.2%)
Apr 2021
$82.00K(-62.7%)
$33.00K(+135.7%)
$82.00K(+43.9%)
Jan 2021
-
$14.00K(+7.7%)
$57.00K(+32.6%)
Oct 2020
-
$13.00K(-40.9%)
$43.00K(-70.1%)
Jul 2020
-
$22.00K(+175.0%)
$144.00K(-34.5%)
Apr 2020
$220.00K
$8000.00(>+9900.0%)
$220.00K(-54.8%)
DateAnnualQuarterlyTTM
Jan 2020
-
$0.00(-100.0%)
$487.00K(-3.9%)
Oct 2019
-
$114.00K(+16.3%)
$507.00K(-17.4%)
Jul 2019
-
$98.00K(-64.4%)
$614.00K(-43.2%)
Apr 2019
$1.08M(-24.2%)
$275.00K(+1275.0%)
$1.08M(-42.8%)
Jan 2019
-
$20.00K(-91.0%)
$1.89M(-7.9%)
Oct 2018
-
$221.00K(-60.9%)
$2.05M(+9.0%)
Jul 2018
-
$565.00K(-47.9%)
$1.88M(+31.9%)
Apr 2018
$1.43M(+1828.4%)
$1.08M(+495.6%)
$1.43M(+307.7%)
Jan 2018
-
$182.00K(+256.9%)
$350.00K(+108.3%)
Oct 2017
-
$51.00K(-53.6%)
$168.00K(+43.6%)
Jul 2017
-
$110.00K(+1471.4%)
$117.00K(+1571.4%)
Apr 2017
$74.00K(-94.6%)
$7000.00(-99.4%)
$7000.00(-99.5%)
Dec 2015
$1.37M(+764.2%)
$1.09M(+5109.5%)
$1.37M(+286.0%)
Sep 2015
-
$21.00K(-73.4%)
$356.00K(+4.1%)
Jun 2015
-
$79.00K(-56.1%)
$342.00K(+1.2%)
Mar 2015
-
$180.00K(+136.8%)
$338.00K(+112.6%)
Dec 2014
$159.00K(+783.3%)
$76.00K(+985.7%)
$159.00K(+93.9%)
Sep 2014
-
$7000.00(-90.7%)
$82.00K(+9.3%)
Jun 2014
-
$75.00K(+7400.0%)
$75.00K(>+9900.0%)
Mar 2014
-
$1000.00(-200.0%)
$0.00(-100.0%)
Dec 2013
$18.00K(-80.2%)
-$1000.00
-$1000.00
Dec 2012
$91.00K
-
-

FAQ

  • What is KalVista Pharmaceuticals, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for KalVista Pharmaceuticals, Inc.?
  • What is KalVista Pharmaceuticals, Inc. annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for KalVista Pharmaceuticals, Inc.?
  • What is the all time high TTM CAPEX for KalVista Pharmaceuticals, Inc.?

What is KalVista Pharmaceuticals, Inc. annual capital expenditures?

The current annual CAPEX of KALV is $929.00K

What is the all time high annual CAPEX for KalVista Pharmaceuticals, Inc.?

KalVista Pharmaceuticals, Inc. all-time high annual capital expenditures is $1.43M

What is KalVista Pharmaceuticals, Inc. annual CAPEX year-on-year change?

Over the past year, KALV annual capital expenditures has changed by +$486.00K (+109.71%)

What is the all time high quarterly CAPEX for KalVista Pharmaceuticals, Inc.?

KalVista Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $1.09M

What is the all time high TTM CAPEX for KalVista Pharmaceuticals, Inc.?

KalVista Pharmaceuticals, Inc. all-time high TTM capital expenditures is $2.05M
On this page